FDA Inspection 1169416 — Nevro Corporation
The FDA completed an inspection of Nevro Corporation on April 26, 2022 in Redwood City, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 26, 2022
- Fiscal Year
- 2022
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Redwood City, CA (United States)
Additional Details
Postmarket Audit Inspections